PMID

Data

Article Title

Organization

Methods for antagonizing a melanocortin 4 receptor

Pfizer

CDK19-Selective Inhibitors, and Methods of Use Thereof

Chan Zuckerberg Biohub

IMIDAZOLE COMPOUNDS AS INHIBITORS OF ENPP1

Stingray Therapeutics

Therapeutic compounds and methods of use

Genentech

Pharmaceutical formulations comprising CCR3 antagonists

Alkahest

Curcumin analogues as zinc chelators and their uses

The Research Foundation For The State University of New York

Compound as ACC inhibitor and use thereof

Nanjing Sanhome Pharmaceutical

Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors

Incyte

Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors

Bayer Pharma Aktiengesellschaft

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

Mitobridge

Alkoxy pyrimidine PDE10 inhibitors

Merck Sharp & Dohme

Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.

Gliatech

Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.

Rhone-Poulenc Sante